Overview

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

Status:
Completed
Trial end date:
2003-12-31
Target enrollment:
0
Participant gender:
All
Summary
A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Aprepitant
Fosaprepitant
Criteria
Patients with Major Depressive Disorder